SLN financials
Silence Therapeutics (SLN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SLN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $559.00K | $344.00K | -$91.08M | -$88.61M | -0.63 |
| 2024 | $43.26M | $31.45M | -$63.32M | -$45.31M | -0.33 |
| 2023 | $31.64M | $18.78M | -$64.38M | -$54.23M | -0.49 |
| 2022 | $21.66M | $8.19M | -$61.04M | -$50.33M | -0.52 |
- SLN revenue was $559.00K in fiscal 2025, net income -$88.61M.
Updated 2026-11-11 00:49 UTC